New Feature Coming Soon, Stay Tuned!
Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer. It develops StemPrintER technology, a multi-gene prognostic assay to predict the risk of recurrence of Endocrine receptor-positive /HER2- breast cancer; and Spare, a derivative of StemPrintER that combines StemPrintER with two clinical markers. The company is based in New York, New York.
PNK
Unprofitable
Unprofitable
-0.05Â ( -11.36%)
Relative Strenght
Volume Buzz
-82%
Earning Acce
No
Dist 52w H.
59%